Today's Family Medicine News Highlights

September 1, 2014

The Globe and Mail

Aids cure possible but is it affordable?


The Toronto Star

Editorial – agreement on need for revamped senior health care strategy
Foreign medical grads find Ontario’s system a challenge


National Post

Comment: Needless controversy on marijuana


Ottawa Citizen

Toddler in Gatineau tested negative for ebola virus


Le Devoir

Questions d’éthique soulevées par l’Ébola
Les personnes handicapées revendiquent plus d’aide du gouvernement
L’entretien des hôpitaux menacé par les coupures 


Le Soleil

Des médecins et experts québécois se prononcent sur les vapoteurs 


Le Journal de Montréal

Détection précoce du cancer de la vessie par du sang invisible dans l’urine


The Medical Post

REGINA | The Saskatchewan government is to begin providing coverage for a cystic fibrosis drug starting next week.

The province says the oral medication Kalydeco will be covered starting Monday.

The drug can be expensive with costs running to $300,000 a year for one patient.

Drug-maker Vertex Pharmaceuticals reached an agreement with the provincial and territorial governments in June to enable public drug plans to cover the medication’s cost.

Negotiations had been going on for more than a year.

It’s believed to be the first drug that corrects the faulty mechanism that causes cystic fibrosis in the first place.

The drug only works for a small subset of patients whose disease is caused by a mutation on the specific gene.

Copyright © 1996-2014 The College of Family Physicians of Canada